These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16675763)

  • 1. Anticonvulsant treatment for psychiatric and seizure indications among youths.
    Zito JM; Safer DJ; Gardner JF; Soeken K; Ryu J
    Psychiatr Serv; 2006 May; 57(5):681-5. PubMed ID: 16675763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National trends in pediatric use of anticonvulsants.
    Tran AR; Zito JM; Safer DJ; Hundley SD
    Psychiatr Serv; 2012 Nov; 63(11):1095-101. PubMed ID: 22983637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal treatment for ADHD among youths in three Medicaid subgroups: disabled, foster care, and low income.
    dosReis S; Owens PL; Puccia KB; Leaf PJ
    Psychiatr Serv; 2004 Sep; 55(9):1041-8. PubMed ID: 15345765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotherapeutic medication prevalence in Medicaid-insured preschoolers.
    Zito JM; Safer DJ; Valluri S; Gardner JF; Korelitz JJ; Mattison DR
    J Child Adolesc Psychopharmacol; 2007 Apr; 17(2):195-203. PubMed ID: 17489714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade.
    Zito JM; Burcu M; Ibe A; Safer DJ; Magder LS
    Psychiatr Serv; 2013 Mar; 64(3):223-9. PubMed ID: 23242390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.
    Zito JM; Safer DJ; Zuckerman IH; Gardner JF; Soeken K
    Psychiatr Serv; 2005 Feb; 56(2):157-63. PubMed ID: 15703342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of first provoked and unprovoked seizure in pediatric patients with and without psychiatric diagnoses.
    McAfee AT; Chilcott KE; Johannes CB; Hornbuckle K; Hauser WA; Walker AM
    Epilepsia; 2007 Jun; 48(6):1075-82. PubMed ID: 17441988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New use of anticonvulsant medications among children enrolled in the Tennessee Medicaid Program.
    Cooper WO; Federspiel CF; Griffin MR; Hickson GB
    Arch Pediatr Adolesc Med; 1997 Dec; 151(12):1242-6. PubMed ID: 9412601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental health services for youths in foster care and disabled youths.
    dosReis S; Zito JM; Safer DJ; Soeken KL
    Am J Public Health; 2001 Jul; 91(7):1094-9. PubMed ID: 11441737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population.
    Chen H; Deshpande AD; Jiang R; Martin BC
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):629-38. PubMed ID: 15597329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rising prevalence of antidepressants among US youths.
    Zito JM; Safer DJ; DosReis S; Gardner JF; Soeken K; Boles M; Lynch F
    Pediatrics; 2002 May; 109(5):721-7. PubMed ID: 11986427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent mental health therapy among medicaid-enrolled youths starting antipsychotic medications.
    Harris E; Sorbero M; Kogan JN; Schuster J; Stein BD
    Psychiatr Serv; 2012 Apr; 63(4):351-6. PubMed ID: 22337007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997-2000.
    Martin A; Leslie D
    Am J Psychiatry; 2003 Apr; 160(4):757-64. PubMed ID: 12668366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths.
    Safer DJ; Zito JM; Gardner JF
    Psychiatr Serv; 2004 Sep; 55(9):1049-51. PubMed ID: 15345766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
    Radigan M; Lannon P; Roohan P; Gesten F
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttraumatic stress disorder and physical comorbidity among female children and adolescents: results from service-use data.
    Seng JS; Graham-Bermann SA; Clark MK; McCarthy AM; Ronis DL
    Pediatrics; 2005 Dec; 116(6):e767-76. PubMed ID: 16322133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment.
    Connor DF; Ozbayrak KR; Harrison RJ; Melloni RH
    J Child Adolesc Psychopharmacol; 1998; 8(1):27-38. PubMed ID: 9639077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mental health treatment received by youths in the year before and after a new diagnosis of bipolar disorder.
    Olfson M; Crystal S; Gerhard T; Huang CS; Carlson GA
    Psychiatr Serv; 2009 Aug; 60(8):1098-106. PubMed ID: 19648198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care.
    Martin A; Van Hoof T; Stubbe D; Sherwin T; Scahill L
    Psychiatr Serv; 2003 Jan; 54(1):72-7. PubMed ID: 12509670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.